Sabra Health Care REIT (SBRA) EBITDA (2016 - 2026)

Sabra Health Care REIT has reported EBITDA for 11 years, with the latest figure at $3.0 million in Q2 2026.

• On a quarterly basis, EBITDA fell 96.76% year-over-year to $3.0 million in Q2 2026; TTM through Jun 2026 was $176.4 million, a 40.09% decrease from a year earlier, with the FY2025 full-year figure at $265.9 million, up 9.25% from the prior year.
• EBITDA was $3.0 million for Q2 2026 at Sabra Health Care REIT, down from $67.8 million in the prior quarter.
• The five-year high for EBITDA was $92.8 million in Q2 2025, with the low at -$18.0 million in Q3 2022.
• Average EBITDA over 5 years is $46.6 million, with a median of $52.1 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: EBITDA sank 146.66% in 2022, then soared 314.18% in 2024.
• Over 5 years, EBITDA stood at $31.4 million in 2022, then jumped by 47.76% to $46.4 million in 2023, then jumped by 62.27% to $75.3 million in 2024, then declined by 27.01% to $54.9 million in 2025, then sank by 94.53% to $3.0 million in 2026.
• The last three EBITDA figures came in at $3.0 million (Q2 2026), $67.8 million (Q1 2026), and $54.9 million (Q4 2025), per Business Quant data.